Phd Candidate
UCL School of Pharmacy, United Kingdom
Luke is a researcher at University College London Hospital and a part-time PhD student at the University College London School of Pharmacy. He collaborates with the Benefits and Risks of Cancer Treatment team in Oxford Population Health on studies of outcomes after chemotherapy. His PhD studies focus on treatment effects of systemic therapies for gynaecological cancers. Other research activities include the development of a predictive model of renal and hepatic function for patients on chemotherapy, the impact of chemotherapy delays on survival outcomes, and management of a quality improvement project aiming to widen access to bispecific antibodies for myeloma patients.